BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 16723969)

  • 1. Brief report: investigation into recalled human tissue for transplantation--United States, 2005-2006.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2006 May; 55(20):564-6. PubMed ID: 16723969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human tissue intended for transplantation--FDA. Interim rule; opportunity for public comment.
    Fed Regist; 1993 Dec; 58(238):65514-21. PubMed ID: 10131341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eligibility determination for donors of human cells, tissues, and cellular and tissue-based products. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2004 May; 69(101):29785-834. PubMed ID: 15160713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human cells, tissues, and cellular and tissue-based products; donor screening and testing, and related labeling. Interim final rule; opportunity for public comment.
    Food and Drug Administration, HHS
    Fed Regist; 2005 May; 70(100):29949-52. PubMed ID: 15915582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reported infections after human tissue transplantation before and after new Food and Drug Administration (FDA) regulations, United States, 2001 through June, 2010.
    Mallick TK; Mosquera A; Zinderman CE; St Martin L; Wise RP
    Cell Tissue Bank; 2012 Jun; 13(2):259-67. PubMed ID: 21479712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human cells, tissues, and cellular and tissue-based products; establishment registration and listing. Interim final rule; opportunity for public comment.
    Food and Drug Administration, HHS
    Fed Regist; 2004 Jan; 69(17):3823-6. PubMed ID: 14968801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tissue allografts and health risks.
    Delloye C
    Acta Orthop Belg; 1994; 60 Suppl 1():62-7. PubMed ID: 7914392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current good tissue practice for human cell, tissue, and cellular and tissue-based product establishments; inspection and enforcement. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2004 Nov; 69(226):68611-88. PubMed ID: 15562555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infections and human tissue transplants: review of FDA MedWatch reports 2001-2004.
    Wang S; Zinderman C; Wise R; Braun M
    Cell Tissue Bank; 2007; 8(3):211-9. PubMed ID: 17278013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Managing a tissue recall in a large academic hospital.
    Steelman VM; Schlueter AJ
    Transfusion; 2007 May; 47(5):927-34. PubMed ID: 17465960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clostridium infections associated with musculoskeletal-tissue allografts.
    Kainer MA; Linden JV; Whaley DN; Holmes HT; Jarvis WR; Jernigan DB; Archibald LK
    N Engl J Med; 2004 Jun; 350(25):2564-71. PubMed ID: 15201413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safeguarding human tissue transplants.
    Henkel J
    FDA Consum; 1994 Sep; 28(7):9-13. PubMed ID: 10139008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The case for regulatory compliance of electronic medical records about human tissue intended for transplantation.
    Carrier R
    J Healthc Inf Manag; 2004; 18(4):61-6. PubMed ID: 15537136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [New Croatian legislation on tissue banking].
    Busić M
    Acta Med Croatica; 2007 Dec; 61(5):445-7. PubMed ID: 18350803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current good manufacturing practice for blood and blood components; notification of consignees and transfusion recipients receiving blood and blood components at increased risk of transmitting hepatitis C virus infection ("lookback"). Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2007 Aug; 72(164):48765-801. PubMed ID: 17886394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How can we improve tracking of transplanted tissue in the United States?
    Mahajan R; Kuehnert MJ
    Cell Tissue Bank; 2014 Sep; 15(3):287-9. PubMed ID: 24281916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FDA takes action on two major tissue banks.
    OR Manager; 2002 Oct; 18(10):9, 15. PubMed ID: 12387235
    [No Abstract]   [Full Text] [Related]  

  • 18. FDA issues new rule on tissue safety.
    OR Manager; 2005 Jan; 21(1):5. PubMed ID: 15707142
    [No Abstract]   [Full Text] [Related]  

  • 19. Lessons learned from independent central review.
    Ford R; Schwartz L; Dancey J; Dodd LE; Eisenhauer EA; Gwyther S; Rubinstein L; Sargent D; Shankar L; Therasse P; Verweij J
    Eur J Cancer; 2009 Jan; 45(2):268-74. PubMed ID: 19101138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood vessels recovered with organs and intended for use in organ transplantation. Final rule.
    Food and Drug Administration, Health Resources and Services Administration, HHS
    Fed Regist; 2007 Mar; 72(47):10922-5. PubMed ID: 17450655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.